1884 results
Keyword Pemetrexed Sun Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Pemetrexed Pfizer (previously Pemetrexed Hospira)
pemetrexed disodium, pemetrexed disodium hemipentahydrate, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 19/11/2015,
, Revision: 14, Authorised, Last updated: 21/09/2022
Pemetrexed Pfizer (previously Pemetrexed Hospira) Cancer Neoplasms Carcinoma … Pemetrexed Pfizer (previously Pemetrexed Hospira … summary for the public Pemetrexed Hospira pemetrexed This is a summary of the … -
List item
Human medicine European public assessment report (EPAR): Sunitinib Accord
sunitinib, Gastrointestinal Stromal Tumors; Carcinoma, Renal Cell; Neuroendocrine Tumors
Date of authorisation: 11/02/2021,
, , Revision: 1, Authorised, Last updated: 14/12/2021
Sunitinib Accord Cancer Neoplasms Neoplasms … Sunitinib Accord … EMA/18013/2021 EMEA/H/C/005419 Sunitinib Accord sunitinib) An overview of Sunitinib Accord and why it is authorised … -
List item
Human medicine European public assessment report (EPAR): Pemetrexed medac
pemetrexed, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 26/11/2015,, Revision: 8, Authorised, Last updated: 09/08/2022
Pemetrexed medac Cancer Neoplasms Carcinoma … Pemetrexed medac … Pemetrexed medac, INN pemetrexed 30 Churchill Place … -
List item
Human medicine European public assessment report (EPAR): Pemetrexed Lilly
pemetrexed, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 14/09/2015,, Revision: 7, Withdrawn, Last updated: 26/11/2021
Pemetrexed Lilly Cancer Neoplasms Carcinoma … Pemetrexed Lilly … EMEA/H/C/004114 Public statement Pemetrexed Lilly Cessation of validity … -
List item
Human medicine European public assessment report (EPAR): Pemetrexed Krka
pemetrexed disodium, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 22/05/2018,, Revision: 5, Authorised, Last updated: 25/08/2022
Pemetrexed Krka Cancer Neoplasms Carcinoma … Pemetrexed Krka … Pemetrexed Krka, INN pemetrexed 30 Churchill Place … -
List item
Human medicine European public assessment report (EPAR): Pemetrexed Fresenius Kabi
pemetrexed, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 22/07/2016,, Revision: 13, Authorised, Last updated: 27/07/2022
Pemetrexed Fresenius Kabi Cancer Neoplasms Carcinoma … Pemetrexed Fresenius Kabi … summary for the public Pemetrexed Fresenius Kabi pemetrexed This is a summary of the … -
List item
Human medicine European public assessment report (EPAR): Pemetrexed Accord
pemetrexed disodium hemipentahydrate, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 18/01/2016,, Revision: 9, Authorised, Last updated: 03/11/2022
Pemetrexed Accord Carcinoma, Bronchogenic Bronchial … Pemetrexed Accord … Pemetrexed Accord, INN pemetrexed EMA/783154/2015 EMEA/H/C/004072 … -
List item
Human medicine European public assessment report (EPAR): Pemetrexed Sandoz
pemetrexed disodium hemipentahydrate, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 18/09/2015,, Revision: 7, Authorised, Last updated: 27/07/2022
Pemetrexed Sandoz Carcinoma, Bronchogenic Bronchial … Pemetrexed Sandoz … summary for the public Pemetrexed Sandoz pemetrexed This is a summary of the … -
List item
Human medicine European public assessment report (EPAR): Pemetrexed Baxter (updated)
pemetrexed disodium heptahydrate, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 09/12/2022,, Authorised, Last updated: 19/01/2023
Pemetrexed Baxter Carcinoma, Bronchogenic Bronchial … Pemetrexed Baxter … EMA/841935/2022 EMEA/H/C/005848 Pemetrexed Baxter pemetrexed) An overview of Pemetrexed Baxter and why it is authorised … -
List item
Withdrawn application: Pemetrexed ditromethamine Hospira
pemetrexed, date of withdrawal: 22/09/2016, Initial authorisation, Last updated: 21/12/2016Pemetrexed ditromethamine Hospira: Withdrawn … Pemetrexed ditromethamine Hospira; INN pemetrexed (as ditromethamine … authorisation application for Pemetrexed (as ditromethamine) Hospira … -
List item
Human medicine European public assessment report (EPAR): Pemetrexed Pfizer (previously known as Pemetrexed Hospira UK Limited)
pemetrexed ditromethamine, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 24/04/2017,, Revision: 7, Withdrawn, Last updated: 29/07/2021
Pemetrexed Pfizer (previously known as Pemetrexed Hospira UK Limited) Carcinoma … Pemetrexed Pfizer (previously known as Pemetrexed Hospira UK Limited … EMEA/H/C/004488 Public statement Pemetrexed Pfizer Cessation of validity … -
List item
Human medicine European public assessment report (EPAR): Armisarte (previously Pemetrexed Actavis) (updated)
pemetrexed diacid monohydrate, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 18/01/2016, Revision: 12, Authorised, Last updated: 18/01/2023Armisarte (previously Pemetrexed Actavis) Cancer Neoplasms Carcinoma … Armisarte (previously Pemetrexed Actavis … the public Armisarte1 pemetrexed This is a summary of the … -
List item
Human medicine European public assessment report (EPAR): Sutent
sunitinib, Gastrointestinal Stromal Tumors; Carcinoma, Renal Cell; Neuroendocrine Tumors
Date of authorisation: 19/07/2006, Revision: 39, Authorised, Last updated: 13/08/2021sunitinib … Sutent; INN-sunitinib 30 Churchill Place … for the public Sutent sunitinib This is a summary of the … -
List item
Human medicine European public assessment report (EPAR): Alimta
pemetrexed, Mesothelioma; Carcinoma, Non-Small-Cell Lung
Date of authorisation: 20/09/2004, Revision: 27, Authorised, Last updated: 03/05/2022pemetrexed … for the public Alimta pemetrexed This is a summary of the … contains the active substance pemetrexed. What is Alimta used for … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Sutent, sunitinib
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Oncology
PIP number: EMEA-000342-PIP01-08-M07, Route(s) of administration: Oral use, Pharmaceutical form(s): Capsule, hard
Decision date: 07/05/2018, Last updated: 27/11/2018, Compliance check: V, 29/06/2018name Sutent Active substance sunitinib Therapeutic area Oncology … Sutent Sutent sunitinib sunitinib sunitinib … -
List item
Human medicine European public assessment report (EPAR): Ciambra
pemetrexed disodium hemipentahydrate, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 02/12/2015,, Revision: 6, Authorised, Last updated: 17/08/2022
pemetrexed … for the public Ciambra pemetrexed This is a summary of the … contains the active substance pemetrexed. http://www.ema.europa.eu/do … -
List item
Withdrawn application: Sutent
sunitinib, date of withdrawal: 26/06/2018, Post-authorisation, Last updated: 17/08/2018authorisation for Sutent (sunitinib) On 26 June 2018, Pfizer … contains the active substance sunitinib. Further information on … active substance in Sutent, sunitinib, is a protein kinase inhibitor … -
List item
Opinion/decision on a Paediatric investigation plan (PIP): Alimta, pemetrexed disodium
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Oncology
PIP number: EMEA-000126-PIP01-07, Route(s) of administration: Intravenous use, Pharmaceutical form(s): Powder for concentrate for solution for infusion
Decision date: 24/02/2009, Last updated: 23/04/2009, Compliance check: Xname Alimta Active substance pemetrexed disodium Therapeutic area … product-specific waiver for pemetrexed disodium (Alimta) (EMEA-000126-PIP01-07 … product specific waiver for pemetrexed disodium (Alimta) (EMEA-000126-PIP01-07 … -
List item
Withdrawn application: Docetaxel SUN
docetaxel, date of withdrawal: 06/06/2016, Initial authorisation, Last updated: 29/09/2016Docetaxel SUN: Withdrawn application … application for Docetaxel Sun (docetaxel) On 6 June … docetaxel) On 6 June 2016, Sun Pharmaceutical Industries … -
List item
Withdrawn application: Topotecan SUN
topotecan, date of withdrawal: 03/01/2011, Initial authorisation, Last updated: 23/02/2011Topotecan SUN: Withdrawn application … Topotecan SUN: Withdrawal of the marketing … application for Topotecan SUN (topotecan) On 3 January … -
List item
Withdrawn application: Repaglinide Sun
repaglinide, date of withdrawal: 25/03/2010, Initial authorisation, Last updated: 15/05/2010Repaglinide Sun: Withdrawn application … Repaglinide Sun: Withdrawal of the marketing … application for Repaglinide Sun (repaglinide) On 23 March … -
List item
Withdrawn application: Doxorubicin SUN
doxorubicin, date of withdrawal: 20/07/2011, Initial authorisation, Last updated: 26/09/2011Doxorubicin SUN: Withdrawn application … application for Doxorubicin SUN (doxorubicin) On 20 Jul … doxorubicin) On 20 Jul 2011, Sun Pharmaceutical Industries … -
List item
Summary of opinion: Sitagliptin / Metformin hydrochloride Sun (new)
sitagliptin, metformin hydrochloride, opinion date: 26/01/2023, Positive, Last updated: 27/01/2023Metformin hydrochloride Sun: Pending EC decision … Metformin hydrochloride Sun … Sitagliptin/Metformin hydrochloride Sun sitagliptin / metformin … -
List item
Human medicine European public assessment report (EPAR): Teriparatide Sun
teriparatide, Osteoporosis; Osteoporosis, Postmenopausal
Date of authorisation: 18/11/2022, Authorised, Last updated: 12/12/2022Teriparatide Sun Bone Diseases, Metabolic Bone … teriparatide Overview Teriparatide Sun is a medicine used to treat … steroid). Teriparatide Sun is a ‘ A medicine that … -
List item
Human medicine European public assessment report (EPAR): Sunosi
solriamfetol hydrochloride, Narcolepsy; Sleep Apnea, Obstructive
Date of authorisation: 16/01/2020,, Revision: 7, Authorised, Last updated: 14/12/2022
Sunosi Nervous System Diseases Sleep … orised solriamfetol Overview Sunosi is a medicine used to improve … disturbed night-time sleep. Sunosi is used in patients with …